As of 2025-06-02, the Intrinsic Value of Organon & Co (OGN) is 52.86 USD. This OGN valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 9.22 USD, the upside of Organon & Co is 473.40%.
The range of the Intrinsic Value is 32.38 - 94.61 USD
Based on its market price of 9.22 USD and our intrinsic valuation, Organon & Co (OGN) is undervalued by 473.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 32.38 - 94.61 | 52.86 | 473.4% |
| DCF (Growth 10y) | 38.09 - 102.05 | 59.24 | 542.5% |
| DCF (EBITDA 5y) | 21.31 - 50.92 | 35.15 | 281.3% |
| DCF (EBITDA 10y) | 29.36 - 62.84 | 44.36 | 381.2% |
| Fair Value | 14.43 - 14.43 | 14.43 | 56.46% |
| P/E | 43.30 - 51.18 | 46.98 | 409.6% |
| EV/EBITDA | 22.60 - 70.72 | 45.46 | 393.1% |
| EPV | 31.92 - 69.16 | 50.54 | 448.2% |
| DDM - Stable | 17.30 - 35.48 | 26.39 | 186.2% |
| DDM - Multi | 16.97 - 27.17 | 20.90 | 126.6% |
| Market Cap (mil) | 2,396.83 |
| Beta | 0.19 |
| Outstanding shares (mil) | 259.96 |
| Enterprise Value (mil) | 10,805.83 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.00% |
| Cost of Debt | 5.50% |
| WACC | 5.71% |